An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 N. Pine St., Baltimore, MD 21201, USA. mlanning@umaryland.edu.
2 Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 N. Pine St., Baltimore, MD 21201, USA. sfletcher@rx.umaryland.edu.
3 University of Maryland Greenebaum Cancer Center, 22 S. Greene St., Baltimore, MD 21201, USA. sfletcher@rx.umaryland.edu.
1 Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 N. Pine St., Baltimore, MD 21201, USA. mlanning@umaryland.edu.
2 Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 N. Pine St., Baltimore, MD 21201, USA. sfletcher@rx.umaryland.edu.
3 University of Maryland Greenebaum Cancer Center, 22 S. Greene St., Baltimore, MD 21201, USA. sfletcher@rx.umaryland.edu.
α-Helices often recognize their target proteins at protein-protein interfaces through more than one recognition face. This review describes the state-of-the-art in the design of non-peptidic α-helix mimetics that reproduce functionality from multiple faces of an α-helix.
An α-helix ( left ) and a terphenyl-based α-helix mimetic ( right ),…
Figure 1
An α-helix (left) and a terphenyl-based α-helix mimetic (right), highlighting the amino acid side chains located on one face. Colours correspond to amino acid side chains and their respective surrogates.
A two-faced helix mimetic centered on a benzoylurea scaffold. Dashed lines represent a…
Figure 6
A two-faced helix mimetic centered on a benzoylurea scaffold. Dashed lines represent a bifurcated hydrogen bond.
Figure 7
An intramolecular hydrogen bond (dashed…
Figure 7
An intramolecular hydrogen bond (dashed line) influences the projection of side-chains from opposing…
Figure 7
An intramolecular hydrogen bond (dashed line) influences the projection of side-chains from opposing faces of a diphenylacetylene scaffold.
Figure 8
Appropriately functionalized anthraquinones ( left …
Figure 8
Appropriately functionalized anthraquinones ( left ) and acridines ( right ) have disrupted…
Figure 8
Appropriately functionalized anthraquinones (left) and acridines (right) have disrupted the Bim–Mcl-1 PPI through two-faced mimicry of the Bim-BH3 α-helix.
Figure 9
2,6,9-Tri-substitution of a purine scaffold…
Figure 9
2,6,9-Tri-substitution of a purine scaffold permits the mimicry of two faces of an…
Figure 9
2,6,9-Tri-substitution of a purine scaffold permits the mimicry of two faces of an α-helix, according to the disruption of the Mcl-1–Bak-BH3 PPI.
Figure 10
In addition to their ability…
Figure 10
In addition to their ability to mimic the epitopes of β-turns and one…
Figure 10
In addition to their ability to mimic the epitopes of β-turns and one face of an α-helix, benzodiazepines have been introduced as scaffolds to reproduce functionality displayed from two faces of an α-helix.
Figure 11
A phenyl-piperazine-triazine helix mimetic disrupts…
Figure 11
A phenyl-piperazine-triazine helix mimetic disrupts the Bim–Mcl-1 PPI. Synthetic strategies to vary the…
Figure 11
A phenyl-piperazine-triazine helix mimetic disrupts the Bim–Mcl-1 PPI. Synthetic strategies to vary the ethyl group should allow the additional mimicry of the i + 5 position on the opposing face.
Figure 12
A novel helix mimetic that…
Figure 12
A novel helix mimetic that projects functionality in a similar orientation to five…
Figure 12
A novel helix mimetic that projects functionality in a similar orientation to five of seven residues spanning two turns of an α-helix.
Fletcher S., Hamilton A.D. Protein surface recognition and proteomimetics: Mimics of protein surface structure and function. Curr. Opin. Chem. Biol. 2005;9:632–638. doi: 10.1016/j.cbpa.2005.10.006.
-
DOI
-
PubMed
Smith M.C., Gestwicki J.E. Features of protein-protein interactions that translate into potent inhibitors: Topology, surface area and affinity. Expert Rev. Mol. Med. 2012 doi: 10.1017/erm.2012.10.
-
DOI
-
PMC
-
PubMed
Nibbe R.K., Chowdhury S.A., Koyutürk M., Ewing R., Chance M.R. Protein-protein interaction networks and subnetworks in the biology of disease. Wiley Interdiscip. Rev. Syst. Biol. Med. 2011;3:357–367. doi: 10.1002/wsbm.121.
-
DOI
-
PubMed
Lessene G., Czabotar P.E., Colman P.M. BCL-2 family antagonists for cancer therapy. Nat. Rev. Drug Discov. 2008;7:989–1000. doi: 10.1038/nrd2658.
-
DOI
-
PubMed
Knight J.D., Miranker A.D. Phospholipid catalysis of diabetic amyloid assembly. J. Mol. Biol. 2004;341:1175–1187. doi: 10.1016/j.jmb.2004.06.086.
-
DOI
-
PubMed